glutamic acid has been researched along with Tauopathies in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 11 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decker, JM; Mandelkow, EM | 1 |
| Choudhary, B; Mandelkow, E; Mandelkow, EM; Pir, GJ | 1 |
| Balu, DT; Cantlon, A; Chen, Z; El Fatimy, R; Elkhal, A; Gongala, S; Krichevsky, AM; Li, S; Mushannen, T; Rabinovsky, R; Selkoe, DJ; Sonntag, KC; Walsh, DM; Wei, Z | 1 |
| Cirrito, JR; Hochgräfe, K; Holth, JK; Holtzman, DM; Jiang, H; Liao, F; Mahan, TE; Mandelkow, EM; Patel, TK; Stewart, FR; Yamada, K | 1 |
| Borthakur, A; Crescenzi, R; DeBrosse, C; Detre, JA; Hariharan, H; Haris, M; Iba, M; Lee, VM; Nanga, RP; Reddy, R; Reddy, S | 1 |
| Gao, X; He, R; Hui, Y; Jin, J; Li, J; Li, L; Li, S; Li, Y; Luo, S; Ma, N; Peng, Y; Tang, L; Wang, D; Zhang, S; Zhou, Y | 1 |
| Baqi, Y; Batalha, VL; Blum, D; Buée, L; Burnouf, S; Coelho, JE; D'Hooge, R; Faivre, E; Ferry, B; Flaten, V; Hamdane, M; Humez, S; Laurent, C; Ledent, C; Lopes, LV; Malik, E; Mariciniak, E; Müller, CE; Parrot, S; Sergeant, N; Van der Jeugd, A | 1 |
| Gerhardt, GA; Hickman, JE; Hunsberger, HC; Libell, EM; Reed, MN; Rudy, CC; Speer, RR; Weitzner, DS | 1 |
| Molnár, E; Whitcomb, DJ | 1 |
| Byrne, MD; Crescenzi, R; D'Aquilla, K; DeBrosse, C; Detre, JA; Hariharan, H; Iba, M; Krishnamoorthy, G; Lee, VM; Morales, KH; Nanga, RP; Nath, H; Reddy, R | 1 |
| Combs, B; Gamblin, TC; Voss, K | 1 |
1 review(s) available for glutamic acid and Tauopathies
| Article | Year |
|---|---|
Presynaptic Pathophysiology Encoded in Different Domains of Tau - Hyper-Versus Hypoexcitability?
Topics: Glutamic Acid; Humans; Mutation; Protein Domains; tau Proteins; Tauopathies | 2019 |
10 other study(ies) available for glutamic acid and Tauopathies
| Article | Year |
|---|---|
Glutamatergic nervous system degeneration in a C. elegans Tau
Topics: Animals; Animals, Genetically Modified; Caenorhabditis elegans; Caenorhabditis elegans Proteins; Calcium Signaling; Glutamic Acid; Nerve Degeneration; tau Proteins; Tauopathies | 2018 |
MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways.
Topics: Amyloid beta-Peptides; Animals; Cell Death; Glutamic Acid; Humans; Mice; Mice, Transgenic; MicroRNAs; Mutation; Nerve Degeneration; Neurites; Neurons; Primary Cell Culture; Protein Processing, Post-Translational; RNA, Long Noncoding; Signal Transduction; tau Proteins; Tauopathies | 2018 |
Neuronal activity regulates extracellular tau in vivo.
Topics: Analysis of Variance; Animals; Brain; Electroencephalography; Enzyme-Linked Immunosorbent Assay; Extracellular Space; Female; Glutamic Acid; Half-Life; Kinetics; Luciferases; Male; Mice; Mice, Transgenic; Microdialysis; Neurons; Synaptic Transmission; tau Proteins; Tauopathies; Tetrodotoxin | 2014 |
In vivo measurement of glutamate loss is associated with synapse loss in a mouse model of tauopathy.
Topics: Animals; Dentate Gyrus; Disease Models, Animal; Glutamic Acid; Hippocampus; Magnetic Resonance Imaging; Mice; Mice, Transgenic; Neurogenesis; Proton Magnetic Resonance Spectroscopy; Synapses; Tauopathies; Thalamus | 2014 |
Overexpression of heme oxygenase 1 causes cognitive decline and affects pathways for tauopathy in mice.
Topics: Animals; Brain; Cognition Disorders; Cyclin-Dependent Kinase 5; Gene Expression Regulation; Glutamic Acid; Heme Oxygenase-1; Humans; Iron; Maze Learning; Mice; Mice, Inbred C57BL; Mice, Transgenic; Phosphorylation; Protoporphyrins; Reaction Time; Reactive Oxygen Species; RNA, Messenger; Spatial Learning; Tauopathies | 2015 |
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy.
Topics: Adenosine A2 Receptor Antagonists; Alzheimer Disease; Animals; Cognition Disorders; Disease Models, Animal; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Humans; Long-Term Synaptic Depression; Mice, Transgenic; Phosphorylation; Receptor, Adenosine A2A; RNA, Messenger; tau Proteins; Tauopathies; Tissue Culture Techniques; Xanthines | 2016 |
Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression.
Topics: Alzheimer Disease; Animals; Brain Chemistry; Cognition Disorders; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Maze Learning; Mice; Mice, Transgenic; Neuroprotective Agents; Riluzole; Synapses; tau Proteins; Tauopathies; Vesicular Glutamate Transport Protein 1 | 2015 |
Is riluzole a new drug for Alzheimer's disease?
Topics: Animals; Cognition Disorders; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Neuroprotective Agents; Riluzole; tau Proteins; Tauopathies | 2015 |
Longitudinal imaging reveals subhippocampal dynamics in glutamate levels associated with histopathologic events in a mouse model of tauopathy and healthy mice.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Disease Progression; Glial Fibrillary Acidic Protein; Glutamic Acid; Hippocampus; Humans; Immunohistochemistry; Longitudinal Studies; Mice, Transgenic; Nerve Tissue Proteins; Neuroglia; Organ Size; Receptors, N-Methyl-D-Aspartate; Synapses; Synaptophysin; tau Proteins; Tauopathies; Vesicular Glutamate Transport Protein 1 | 2017 |
Pseudohyperphosphorylation has differential effects on polymerization and function of tau isoforms.
Topics: Amino Acid Substitution; Arachidonic Acid; Aspartic Acid; Biopolymers; Glutamic Acid; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Mutagenesis, Site-Directed; Phosphorylation; Protein Isoforms; Serine; tau Proteins; Tauopathies; Threonine | 2011 |